MapLight Therapeutics, Inc. (MPLT)

6.22 -0.49 (-7.30%) USD  |  NASDAQ  |  Nov 05, 16:00
6.33 +0.11 (+1.77%) After-Hours: 20:00
More

MapLight Therapeutics SG&A Expense (TTM) : 44.09M for June 30, 2026

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 44.09M
March 31, 2026 37.79M
December 31, 2025 26.98M
September 30, 2025 8.221M
June 30, 2025 3.817M
Date Value
March 31, 2025 0.00
June 30, 2024 0.00
March 31, 2024 0.00
March 31, 2023 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Cullinan Therapeutics, Inc. 50.33M
Arrowhead Pharmaceuticals, Inc. 172.57M
Oncolytics Biotech, Inc. 16.62M
Sangamo Therapeutics, Inc. 31.64M
Sarepta Therapeutics, Inc. 436.74M